Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL)
Old Forum Content for ZNTL
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: And to keep things in one place, here are other #Biotech stocks I mentioned a couple days ago. $YMAB $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX.
- Babutters: @woodman $YMAB $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX #Biotech yessir. Love the show although wasn’t impressed with the last season (if you watched the F1 season you would understand where I’m coming from). I used your list to create a new list on my YF account. Good stuff - and more studying.
- Docoof: @woodman $YMBA $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX #biotech Thank you for posting this—after hours I review all your very helpful posts. $YMBA (typo) = $YMAB.
- woodman: @Docoof $YMBA $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX $YMAB #biotech - Thank you for the correction! Sorry I've not been so engaged the last several weeks. I've largely been taking a break during the Market malaise, attending to personal and professional matters, enjoying time with my family, and getting some golf time in as well. I am trading here and there, holding very little (currently just a few biotech or related holdings), but now trying to re-engage more so as to not be totally tuned out. Eventually, the tide will change and I don't want to be completely disengaged. But on the whole, I'm not very active in this market.
- woodman: Some nice #biotech movers: For example: $YMBA $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX. Many others.
- woodman: Some pullback bouncers: $AVTR $HOLX $ZS $TENB $U $DGX $LH $REGN $SWCH $DHR $CNC $TTD $RNR $TMO $ZNTL $DDOG $PZZA $ANET $QDEL
- Pokersmith: @woodman $AVTR $HOLX $ZS $TENB $U $DGX $LH $REGN $SWCH $DHR $CNC $TTD $RNR $TMO $ZNTL $DDOG $PZZA $ANET $QDEL compelling list, thx
- woodman: @Pokersmith $AVTR $HOLX $ZS $TENB $U $DGX $LH $REGN $SWCH $DHR $CNC $TTD $RNR $TMO $ZNTL $DDOG $PZZA $ANET $QDEL - Perhaps a couple nuggets in that pan.
-
Carpe_Diem: $ZNTL - Zentalis Pharmaceuticals Announces Publication in the Journal of Medicinal Chemistry Highlighting the Discovery of its WEE1 Inhibitor Candidate ZN-c3
7:03 am ET September 1, 2021 (Benzinga) Print
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), ... - Carpe_Diem: $ZNTL - Has been heading higher since @Dan mentioned it on 08/20. I'm starting to peel a little off as it has had a huge move ..... Thanks again @Dan this was a powerful move.
- DAN: @Carpe_Diem $ZNTL Nice job! Stay thirsty.
-
DAN: ...
$ZNTL -- covered on 8/20. Up 21% since that breakout.
$DOCS -- covered yesterday. Good move today on volume.
- Carpe_Diem: $ZNTL - Opened strong and is heading in the right direction. ThXS @Dan for the heads upon the weekend Session!
-
DAN: ...
$ZNTL -- IPO biotech...coming off the bottom. Stop below the 50-day MA would work.
$MSTR -- walking higher.
$RIOT -- Looks like Mister.
$RH -- Really good base being formed.
- Louis Berg: $ZNTL like VCP action on a weekly chart.
- Wykeman: Three Ipo's trading well today. $ZNTL $NET and $PASG take a look.
- traderbren: #IPO_strategy -- just came across $ZNTL a recent IPO that just cleared a prior high and may have the juice to continue. This is day 5, so it may need to move sideways or rest before starting the next leg higher. Maybe some of our resident biotech wizards know more about this stock.
- sierramp: @traderbren $ZNTL #IPO_strategy That's sure not the typical frightening IPO chart. Looking forward to input from the biotech wizards.
- Herb: $ZNTL just noticed this recent ipo. np.
- shoredriver: $ZNTL.....IPO from last week...still cranking....
| Stock Price | $11.71 |
| Change | 5.40% |
| Volume | 498,077 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. The company's product candidate, ZN-c5, is an oral selective estrogen receptor degrader, or SERD, currently in a Phase 1/2 clinical trial for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer. Its other products include ZN-c3, ZN-d5, and ZN-e4.
Request Video of ZNTLAlready a member? Sign in here.
Past Month
Leading Peers
-
$13.07 324.37%
-
$7.74 301.40%
-
$10.15 127.59%
Past Month
Lagging Peers
-
$5.18 -75.67%
-
$9.35 -32.96%
-
$15.84 -32.67%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!